Tegretol Spina Bifida Lawsuit Results in Settlement by Wal-Mart
Walmart is seeking compensation from a drug manufacturer, after it agreed to settle a birth defect lawsuit brought by a couple whose son was born with spina bifida after exposure to Tegretol during pregnancy.
The company indicated on Monday that it has reached a settlement for an undisclosed amount in a claim brought by Paul and Jean Pendino, who alleged that Walmart failed to warn them about the risk of Tegretol birth defects.
Walmart indicates that it did not warn the couple because the manufacturers of the epilepsy drug, PDX and Landmark Data, did not include a warning for pregnant women in the materials provided to Walmart, according to a report by Courthouse News Service.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Landmark Data is now known as the National Health Information Network.
According to Walmart, the only warning regarding pregnancy that came with the Tegretol was that it may decrease the effectiveness of birth control. Walmart is now pursuing compensation for what it paid to the Pendinos from the drug companies.
Previous studies have indicated that side effects of Tegretol increase the risk of spina bifida, which is a developmental malformation involving the spinal cord, where some vertebrae are not fully formed. The condition may allow portions of the spinal cord to protrude through the opening in the bones, leading to serious life-long injuries for the child
According to a 2010 study published in the British Medical Journal (BMJ), use of Tegretol (carbamazepine) during pregnancy was associated with 2.6 times the risk of giving birth to a child with spina bifida, compared to women who did not take the drug. Overall, 3.3% of women who took the drug gave birth to a child with spina bifida.
Tegretol was first approved in the U.S. in 1974 as an anticonvulsant. It is approved for the treatment of epilepsy, trigeminal neuralgia and bipolar disorder.
"*" indicates required fields
More Top Stories
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.
The U.S. JPML has consolidated all Tepezza lawsuits over hearing loss before one Northern Illinois federal judge for coordinated pretrial proceedings.
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.